Clinical Trial Update: Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing suprachoroidal CLS-TA with intravitreal aflibercept versus aflibercept alone in diabetic macular edema has completed, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)
• CLS-TA (suprachoroidal topicalized triamcinolone acetonide) (triamcinolone acetonide)

Snippet

Sponsor: Clearside Biomedical, Inc. | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2021-05-13